Congratulations to Dr. Albert DeNittis and Dr. Ned Carp who were named in Philadelphia Magazine’s annual “Top Doctors” list for their work in radiation oncology and surgery, respectively. We are so proud to have them on our team! Click here to learn more about the “Top Doctors” list.
June is dedicated to raising awareness and prevention of the preventable health problems men face while encouraging men to seek regular medical advice and early treatment for disease or injury. One of the common health threats to men is prostate cancer. In 2012, the American Cancer Society estimates about 241,740 new diagnoses of prostate cancer. […]
May marks the recognition of National Brain Tumor Awareness Month. Since its establishment in 2008, community organizations and support groups celebrate this month with increased efforts to raise awareness of brain tumors, increase funding for research and educate the public on symptoms and treatment options.
The Central Brain Tumor Registry estimates 66,290 new cases of primary non–malignant and malignant brain and central nervous system tumors will be diagnosed in the United States in 2012. What patients may not know is that a large percentage of those diagnoses will be from metastatic tumors, tumors that develop from cancer cells that have spread from another part of the body.
There are more than 120 different types of brain tumors, and while not all are necessarily fatal, any brain tumor should be considered a serious health condition. Brain tumors often create increased pressure in the skull, known as intracranial hypertension. This can lead to, among other conditions, headaches, vomiting, vision problems and altered states of consciousness.
Philadelphia CyberKnife has been credentialed by the Radiological Physics Center (RPC), an organization funded by the National Cancer Institute (NCI) to provide quality assurance auditing of dosimetry practices at institutions participating in NCI cooperative clinical trials. The RPC assures the NCI and cooperative clinical trial groups that all participating institutions have the equipment, personnel and […]
A research paper presented and authored by Philadelphia CyberKnife chief medical physicist Jun Yang, Ph.D. was awarded “Best Presentation” in the physics category at The Radiosurgery Society’s 2012 SRS/SBRT Meeting in California. The annual meeting brings together physicians, physicists, residents and researchers from around the world who are involved in stereotactic radiosurgery (SRS) and stereotactic […]
The research of the CyberKnife physician team was recently published in Frontiers in Oncology. Dr. Rachelle Lanciano, Dr. John Lamond, Dr. Steve Arrigo, Dr. Luther Brady, CyberKnife nurse Michael Good, and medical physicists Jing Feng and Jun Yang studied the effects of CyberKnife treatment on patients with liver metastases and liver tumors. The study, titled […]
In recognition of Patient Safety Awareness Week, Philadelphia CyberKnife joins a nation-wide effort to encourage engagement of patients, families and the community by promoting the importance of being an active participant in the health care delivery process.